AMLN - in at 10.86

During earnings season, I like to stay out of it except for my long term holdings.  I do make short term plays on investors' over reaction though.

I just saw this article:

Amylin shares pop on analyst upgrade

October 27, 2010 4:51 PM ET

NEW YORK (AP) - Shares of Amylin Pharmaceuticals Inc. jumped 10 percent Wednesday after an analyst suggested investors had oversold the stock last week when Amylin announced a delay of its highly anticipated diabetes drug Bydureon.

Read full article